Plasma P‐tau181 is increased in Alzheimer’s disease (AD), and correlates with brain deposition of aggregated β‐amyloid (Aβ) and tau, the core AD hallmarks.1, 2, 3. This evidence concerns the gene OCA2 and Alzheimer disease.